Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Butcher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncology|May 1, 1993
Global experience with ondansetron and future potentialM E Butcher
Cancer Treatment Reviews|September 1, 1990
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetronA E Kidgell, M E Butcher, G W Brown
Scandinavian Journal of Infectious Diseases|January 1, 1987
The emergence of resistance of Pseudomonas aeruginosa in patients treated with ceftazidimeR D Foord, M E Butcher, A H Williams
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalanC V Viner, P J Selby, G B Zulian, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncology|May 1, 1993
Global experience with ondansetron and future potentialM E Butcher
Cancer Treatment Reviews|September 1, 1990
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetronA E Kidgell, M E Butcher, G W Brown
Scandinavian Journal of Infectious Diseases|January 1, 1987
The emergence of resistance of Pseudomonas aeruginosa in patients treated with ceftazidimeR D Foord, M E Butcher, A H Williams
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalanC V Viner, P J Selby, G B Zulian, et al.
Pageof 1